BRIEF-Akers Biosciences reports earnings for fiscal year 2016
April 11, 2017 at 07:15 AM EDT
* Akers Biosciences - Expect 2017 to be characterized by further growth in flagship PIFA Heparin PF/4 rapid assay product line, sales of rapid cholesterol test Source text for Eikon: Further company coverage: